1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AIS-1061-9320, NCI-V95-0689
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: Other
Protocol IDs: UCLA-HSPC-9502083, NCI-V96-0944
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-86-C-183E, NCI-T86-0225N, T86-0225
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NBSG-8720, NCI-V88-0615
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: UCLA-9102071, UCLA-UO-91-1, NCI-B91-0006, B91-0006
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: PCI-9038, NCI-T91-0133O, T91-0133
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCLA-9102052, NCI-V91-0217
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NBSG-9201, NCI-V92-0156
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: JHOC-J0770, J0770, NCT00566098
|
|
10.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: 1017.01, FHCRC-1017.01, NCI-V96-0920, CDR0000064846, NCT00002786
|
|
11.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: CDR0000256870, MSGCC-0065, UPCC-6401, NCI-V02-1709, NCT00046852
|
|
12.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, NIH WGMCC
Protocol IDs: 030162, 03-C-0162, NCI-5855, CDR0000304438, NCT00062036
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 16
Sponsor: Other
Protocol IDs: STLMC-BRM-93006, NCI-V94-0365
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NBSG-9401, NCI-V94-0455
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NBSG-9403, NCI-V94-0457
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-GYN-94001, NCI-T94-0052D, T94-0052
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 16
Sponsor: Other
Protocol IDs: STLMC-BRM-93005, NCI-V94-0505
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-95-C-0105A, NCI-T94-0096N, T94-0096, NCT00019084
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-ID-96017, NCI-T96-0016D, T96-0016
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: 990158, 99-C-0158, NCI-99-C-0158, NCI-T99-0078, T99-0078, NCT00019942, NCT00001832
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-10M991, NCI-G00-1837, NCI-T99-0102, NCT00006113, T99-0102
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 2 and over
Sponsor: NCI
Protocol IDs: NCI-90-C-0029A, NCI-T89-0227N, T89-0227
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCF-RPC-3209, NCI-T89-0218O, T89-0218
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-89-C-67, NCI-T89-0019N, T89-0019
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: STLMC-BRM-89-0001, NCI-V90-0025
|
Mobile | Español
